Arch Pediatr
- CATHALAU M, Michelet M, Rance A, Martin-Blondel G, et al
Necrotizing pneumonia in children: Report of 25 cases between 2008 and 2018 at a
French tertiary care center.
Arch Pediatr. 2024;31:183-187.
Clin Infect Dis
- SHERMAN A, Tuan J, Cantos VD, Adeyiga O, et al
COVID-19 vaccine efficacy in participants with weakened immune systems from four
randomized-controlled trials.
Clin Infect Dis. 2024 Apr 10:ciae192. doi: 10.1093.
- RYBAK A, Assad Z, Levy C, Bonarcorsi S, et al
Age-specific resurgence in invasive pneumococcal disease incidence in the
COVID-19 pandemic era and its association with respiratory virus and pneumococcal
carriage dynamics: a time series analysis.
Clin Infect Dis. 2023 Dec 6:ciad746. doi: 10.1093.
Indian Pediatr
- JOHN TJ, Dharmapalan D, Steinglass R, Hirschhorn N, et al
Novel OPV is Still not the Right Tool for Polio Eradication.
Indian Pediatr. 2024;61:387.
- ABU BASHAR MD, Ahmed Khan I, Sridevi G
Recent Surge in Mumps Cases in India: Need for Urgent Remedial Measures.
Indian Pediatr. 2024;61:370-374.
Infect Immun
- XING Y, Clark JR, Chang JD, Zulk JJ, et al
Progress toward a vaccine for extraintestinal pathogenic E. coli (ExPEC) II:
efficacy of a toxin-autotransporter dual antigen approach.
Infect Immun. 2024 Apr 9:e0044023. doi: 10.1128/iai.00440.
J Infect Dis
- WALSH EE, Falsey AR, Zareba AM, Jiang Q, et al
Respiratory Syncytial Virus Prefusion F Vaccination: Antibody Persistence and
Revaccination.
J Infect Dis. 2024 Apr 12:jiae185. doi: 10.1093.
- SABAWOON W, Seino S, Pason BM, Momin NWS, et al
Progress in Access and Oral Polio Vaccine Coverage Among Children Aged <5 Years
in Polio Campaigns After the Political Change in Afghanistan.
J Infect Dis. 2024 Apr 10:jiae129. doi: 10.1093.
- CHEN MH, Perelygina L, Hao L, Beard RS, et al
Neutralization of Rubella Vaccine Virus and Immunodeficiency-Related
Vaccine-Derived Rubella Viruses by Intravenous Immunoglobulins.
J Infect Dis. 2024 Apr 9:jiae182. doi: 10.1093.
- PONZILACQUA-SILVA B, Dadelahi AS, Abushahba MFN, Moley CR, et al
Vaccine Elicited Antibodies Restrict Glucose Availability to Control Brucella
Infection.
J Infect Dis. 2024 Apr 8:jiae172. doi: 10.1093.
- BARTSCH SM, O'Shea KJ, Weatherwax C, Strych U, et al
What is the economic benefit of annual COVID-19 vaccination from the adult
individual perspective?
J Infect Dis. 2024 Apr 6:jiae179. doi: 10.1093.
J Virol
- TANG X, Li S, Zhou J, Bian X, et al
Recombinant bivalent subunit vaccine combining truncated VP4 from P[7] and P[23]
induces protective immunity against prevalent porcine rotaviruses.
J Virol. 2024 Apr 9:e0021224. doi: 10.1128/jvi.00212.
- QUADIRI A, Prakash S, Dhanushkodi NR, Singer M, et al
Therapeutic prime/pull vaccination of HSV-2-infected guinea pigs with the
ribonucleotide reductase 2 (RR2) protein and CXCL11 chemokine boosts antiviral
local tissue-resident and effector memory CD4(+) and CD8(+) T cells and protects
against recurrent
J Virol. 2024 Apr 8:e0159623. doi: 10.1128/jvi.01596.
JAMA
- HARRIS E
Safety Concerns Put a Stop to Maternal RSV Vaccine Study.
JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5155.
- HARRIS E
COVID-19 Vaccination Linked With Lower Risk of Cardiac Problems.
JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5152.
- HARRIS E
Measles Outbreaks in US and Abroad Prompt CDC Vaccination Alert.
JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5153.
- ANDERER S
Could "Empathetic Refutation" Help Clinicians Sway Vaccine Skeptics?
JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.4493.
Lancet
- ASANTE KP, Mathanga DP, Milligan P, Akech S, et al
Feasibility, safety, and impact of the RTS,S/AS01(E) malaria vaccine when
implemented through national immunisation programmes: evaluation of
cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi.
Lancet. 2024 Apr 4:S0140-6736(24)00004-7. doi: 10.1016/S0140-6736(24)00004.
- DAUBENBERGER CA, Silva JC
First-generation malaria vaccine successfully implemented in three African
countries.
Lancet. 2024 Apr 4:S0140-6736(23)02892-1. doi: 10.1016/S0140-6736(23)02892.
MMWR Morb Mortal Wkly Rep
- LIKO J, Cieslak PR
Assessment of Risk for Sudden Cardiac Death Among Adolescents and Young Adults
After Receipt of COVID-19 Vaccine - Oregon, June 2021-December 2022.
MMWR Morb Mortal Wkly Rep. 2024;73:317-320.
- DOSHI RH, Nsasiirwe S, Dahlke M, Atagbaza A, et al
COVID-19 Vaccination Coverage - World Health Organization African Region,
2021-2023.
MMWR Morb Mortal Wkly Rep. 2024;73:307-311.
N Engl J Med
- HAMMOND J, Fountaine RJ, Yunis C, Fleishaker D, et al
Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19.
N Engl J Med. 2024;390:1186-1195.
Nat Med
- ARNOLD C
'Inverse vaccines' could treat autoimmune disease - from multiple sclerosis to
celiac disease.
Nat Med. 2024 Apr 10. doi: 10.1038/d41591-024-00024.
- YARCHOAN M, Gane EJ, Marron TU, Perales-Linares R, et al
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular
carcinoma: a phase 1/2 trial.
Nat Med. 2024 Apr 7. doi: 10.1038/s41591-024-02894.
PLoS One
- UNFRIED K, Priebe J
Who shares fake news on social media? Evidence from vaccines and infertility
claims in sub-Saharan Africa.
PLoS One. 2024;19:e0301818.
- ALAMARES-SAPUAY J, Kishko M, Lai C, Parrington M, et al
Mutations in the F protein of the live-attenuated respiratory syncytial virus
vaccine candidate DeltaNS2/Delta1313/I1314L increase the stability of infectivity and
content of prefusion F protein.
PLoS One. 2024;19:e0301773.
Vaccine
- LEE JS, Choi H, Shin SH, Hwang MJ, et al
Characterization of Brighton Collaboration criteria for myocarditis and
pericarditis following COVID-19 vaccine in Korean adolescents.
Vaccine. 2024 Apr 11:S0264-410X(24)00446-8. doi: 10.1016/j.vaccine.2024.
- PITTS PJ, Poland GA
Addressing vaccine hesitancy: Learning from the successes and failures of the
COVID-19 pandemic.
Vaccine. 2024 Apr 10:S0264-410X(24)00396-7. doi: 10.1016/j.vaccine.2024.
- HUBER A, Kovacs E, Horvath A, Sahin-Toth J, et al
Prevalence, serogroup distribution and risk factors of Neisseria meningitidis
carriage in high school and university students in Hungary.
Vaccine. 2024;42:2271-2277.
- SU L, Zhou X, Peng W, Luo J, et al
Investigation on the correlation factors of positive Streptococcus pneumoniae
antibody and IgG antibody level of Streptococcus pneumoniae in the elderly over
60 years old in Shenzhen.
Vaccine. 2024;42:2448-2454.
- ST-LOUIS P, Martin C, Khatri V, Bourgault S, et al
Intranasal delivery of a self-adjuvanted nanovaccine composed of the curli
filaments and the highly conserved M2e epitope confers protection against
influenza a virus in mice.
Vaccine. 2024 Mar 8:S0264-410X(24)00222-6. doi: 10.1016/j.vaccine.2024.
- LIU J, Qi Q, Liu Y, Ni P, et al
A paired measles-rubella catch-up campaign in Sichuan China to stop an outbreak
and strengthen local immunization programs.
Vaccine. 2024;42:2155-2160.
- WU CY, Kao SE, Tseng YC, Hou JT, et al
Pilot-scale production of a highly efficacious and stable monoglycosylated
influenza split virus vaccine.
Vaccine. 2024;42:2220-2228.
- NAKANO T, Hasegawa M, Endo M, Matsuda K, et al
Immunogenicity and safety of adsorbed diphtheria-purified
pertussis-tetanus-inactivated polio (Sabin strain)-Haemophilus type b conjugate
combined vaccine (DPT-IPV-Hib) in healthy Japanese Infants >/= 2 and < 43 months of
Age: A phase III, multicenter
Vaccine. 2024 Apr 5:S0264-410X(24)00394-3. doi: 10.1016/j.vaccine.2023.
- NYBRU GLEDITSCH R, Skogset Ofitserova T, Aubrey White R, Karoline Raberg Kjollesdal M, et al
Vaccine coverage among children born to immigrant parents in Norway, 2000-2020.
Vaccine. 2024 Apr 5:S0264-410X(24)00395-5. doi: 10.1016/j.vaccine.2024.
- STEFANIZZI P, Moscara L, Palmieri C, Martinelli A, et al
Safety profile of recombinant adjuvanted anti-herpes zoster vaccine (RZV) in
high-risk groups: Data from active surveillance program. Puglia (Italy), 2021-23.
Vaccine. 2024 Apr 5:S0264-410X(24)00311-6. doi: 10.1016/j.vaccine.2024.
- CHARD AN, Machingaidze C, Loayza S, Gharpure R, et al
Estimating averted illnesses from influenza vaccination for children and pregnant
women - El Salvador, Panama, and Peru, 2011-2018.
Vaccine. 2024 Apr 6:S0264-410X(24)00419-5. doi: 10.1016/j.vaccine.2024.
- BINTE HOSSAIN F, Muscatello D, Jayasinghe S, Jonnagaddala J, et al
Uptake of pneumococcal vaccines in older Australian adults before and after
universal public funding of PCV13.
Vaccine. 2024 Apr 6:S0264-410X(24)00426-2. doi: 10.1016/j.vaccine.2024.
- CHONG CY, Kam KQ, Zhang J, Bertoletti A, et al
Immunogenicity and safety of Sinovac-CoronaVac booster vaccinations in 12-17-
year-olds with clinically significant reactions from Pfizer-BNT162b2 vaccination.
Vaccine. 2024 Apr 6:S0264-410X(24)00425-0. doi: 10.1016/j.vaccine.2024.
- CUMMINGS JF, Polhemus ME, Kester KE, Ockenhouse CF, et al
A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial
of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S
formulated with AS02 adjuvant in healthy, malaria-naive adults.
Vaccine. 2024 Apr 6:S0264-410X(24)00389-X. doi: 10.1016/j.vaccine.2024.
- ARCHER H, McCoy SI, Sears D, Kwan A, et al
Indirect vaccine effectiveness in an outbreak of Alpha B.1.1.7 variant in a
California state Prison, May 2021.
Vaccine. 2024 Apr 6:S0264-410X(24)00368-2. doi: 10.1016/j.vaccine.2024.
- ZURCHER SJ, Signorell A, Lechot-Huser A, Aebi C, et al
Childhood vaccination coverage and regional differences in Swiss birth cohorts
2012-2021: Are we on track?
Vaccine. 2023;41:7226-7233.
- AKMATOVA R, Ebama MS, Temirbekov S, Alymkulova V, et al
A comparative analysis of knowledge, attitude, and practice (KAP) towards
influenza and influenza vaccination among healthcare workers in Kyrgyzstan prior
to and during the COVID-19 pandemic.
Vaccine. 2024 Apr 9:S0264-410X(24)00420-1. doi: 10.1016/j.vaccine.2024.
- KONERU A, Wells K, Amanda Carnes C, Drumhiller K, et al
A survey of state and local practices encouraging pediatric COVID-19 vaccination
of children ages 6 months through 11 years.
Vaccine. 2024 Apr 8:S0264-410X(24)00369-4. doi: 10.1016/j.vaccine.2024.
- EL BUSHRA HE, Haroun AAA, Dauod Altaf M, Gardiwal H, et al
Early use of oral cholera vaccines as a prime control measure during outbreaks:
Necessary but not sufficient.
Vaccine. 2024 Apr 8:S0264-410X(24)00332-3. doi: 10.1016/j.vaccine.2024.
- THAI H, Audet EC, Koestner R
Motivation for COVID-19 Vaccination: Applying a Self-Determination Theory
Perspective to a Global Health Crisis.
Vaccine. 2024 Apr 9:S0264-410X(24)00439-0. doi: 10.1016/j.vaccine.2024.
- KAINTH MK, Sembajwe GN, Ahn H, Qian M, et al
Despite mandated primary series, health care personnel still hesitant about
COVID-19 vaccine and immunizing children.
Vaccine. 2024 Apr 11:S0264-410X(24)00442-0. doi: 10.1016/j.vaccine.2024.
- NOLAN MB, Chrenka E, Walker P, Steiner A, et al
COVID-19 vaccine uptake among non-US-born populations in the United States,
2020-2022.
Vaccine. 2024 Apr 11:S0264-410X(24)00443-2. doi: 10.1016/j.vaccine.2024.
- BLAKE JM, Thompson J, HogenEsch H, Ekenstedt KJ, et al
Heritability and genome-wide association study of vaccine-induced immune response
in Beagles: A pilot study.
Vaccine. 2024 Apr 10:S0264-410X(24)00398-0. doi: 10.1016/j.vaccine.2024.
- HUSETH-ZOSEL AL, Fuller H, Hicks A, Carson PJ, et al
Reliance on sources of immunization information and vaccine uptake among older
adults in a rural state: The mediating role of trust.
Vaccine. 2024 Apr 10:S0264-410X(24)00444-4. doi: 10.1016/j.vaccine.2024.
Virology
- ABDEL-MONEIM AS, Murovska M, Soderlund-Venermo M, Vakharia VN, et al
WSV2023 - The second meeting of the world society for virology: One health - One
world - One virology.
Virology. 2024;594:110049.
- HE X, Jiang N, Li Y
Saccharomyces cerevisiae cells that display norovirus P induce both systemic and
mucosal neutralizing antibodies.
Virology. 2024;594:110034.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016